Patents Assigned to Seatle Genetics, Inc. - Justia Patents Search

Patents Assigned to Seatle Genetics, Inc.

Synergistic Effects Between Auristatin-Based Antibody Drug Conjugates And Inhibitors Of The PI3K-AKT mTOR Pathway

Publication number: 20130209496

Abstract: The present invention is directed to methods for treating cancer comprising administering to a subject in need thereof an auristatin-based antibody drug conjugate and an inhibitor of the PI3K-AKT-mTOR pathway.

Type: Application

Filed: October 20, 2011

Publication date: August 15, 2013

Applicant: Seatle Genetics, Inc.

Inventors: Timothy S. Lewis, Che-Leung Law, Julie A. McEarchern